Fundraising Fox

Route 92 Medical

San Mateo, US · Founded 2015 · Delaware corporation · 202 employees on LinkedIn · 5 known investors

Find your way into Route 92 Medical

235 people in our graph share verified history with the Route 92 Medical team — schools, employers, funds. One of them is your warm intro.

Nick Pianimunlockedknows Cindy Lynch · together at Tufts University (overlapped)
×9knows the team · via San Francisco State University
knows the team · via Burns, Doane, Swecker & Mathis, LLP
knows the team · via Moximed

Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment. Its products are designed to navigate tortuous vascular anatomy and reach target locations for procedures such as aspiration.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

Route 92 Medical was founded in 2015 by Dr. Chou.

DC
Dr. ChouFounder & Chief Executive Officer
CLCindy Lynch
Cindy LynchinSenior VP of Legal AffairsCindy Lynch is an attorney with experience in intellectual property and corporate counsel, having worked with early-stage companies through various growth stages including venture financing, public offerings, and acquisitions. She is Executive Officer of Route 92 Medical, which develops neurointervention catheter systems for neurovascular procedures.
TCTony Chou
Tony ChouinNamed on SEC filingGeneral Partner at The Vertical Group

Board

JLJack Lasersohn
Jack LasersohninBoard directorGeneral Partner at The Vertical Group
TM
Tamir MeiriBoard director
JRJonathan Root
Jonathan RootinBoard directorGeneral Partner at US Venture Partners
AG
Ariella GolombBoard director
NJNoel Jee
Noel Jeein𝕏Board directorPrincipal at Sofinnova Ventures
CDCasper de Clercq
Casper de Clercqin𝕏Board directorGeneral Partner at Norwest Venture Partners
JEJohn E. Runnells
John E. RunnellsinBoard directorGeneral Partner at The Vertical Group

Investors · 5

Norwest Venture PartnersMenlo Park · $10M – $30Mvia Casper de Clercq · board
Runway Growth CapitalMenlo Park · $10M – $150M
US Venture PartnersMenlo Park · $500K – $10M
Sofinnova VenturesreportedMenlo Park · $100K – $15Mvia Noel Jee · board
The Vertical GroupreportedBerkeley Heights · $250K – $5Mvia Jack W. Lasersohn · board

Reported raises · per SEC filings

Form D private placements

$208.1M disclosed across 8 rounds · 2016–2026

▶$50MraisedApr 2026 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony M. ChouExecutive Officer, Director
  • Ariella GolombDirector
  • John MillerExecutive Officer
  • Noel JeeDirector
  • Jonathan RootDirector
  • Jack W. LasersohnDirector
  • J. Patrick MackinDirector
  • Mitchell HillDirector
  • Cindy LynchExecutive Officer
  • Lucas BuchananDirector
  • Randall SullivanExecutive Officer
  • Kirsten ValleyExecutive Officer
  • Chris HartmanExecutive Officer
  • Casper de ClercqDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50.4MraisedJul 2024 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • Jack LasersohnDirector
  • Tamir MeiriDirector
  • Jonathan RootDirector
  • Cindy LynchExecutive Officer
  • Ariella GolombDirector
  • Noel JeeDirector
  • Casper de ClercqDirector
Offering amount
$50.4M
Amount sold
$50.4M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.3MraisedNov 2023 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack LasersohnDirector
  • Cindy LynchExecutive Officer
  • Jonathan RootDirector
  • Tony ChouExecutive Officer, Director
  • Casper de ClercqDirector
  • Ariella GolombDirector
Offering amount
$31.3M
Amount sold
$31.3M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$46.9MraisedJul 2021 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • Ariella GolombDirector
  • Jonathan RootDirector
  • Jack LasersohnDirector
  • Casper de ClercqDirector
  • Cindy LynchExecutive Officer
Offering amount
$61M
Amount sold
$46.9M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedMay 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • Jonathan RootDirector
  • Casper de ClercqDirector
  • John E. RunnellsExecutive Officer
  • Jack LasersohnDirector
Offering amount
$13M
Amount sold
$13M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John E. RunnellsExecutive Officer
  • Jack LasersohnDirector
  • Tony ChouExecutive Officer, Director
  • Jonathan RootDirector
Offering amount
$6.7M
Amount sold
$4.7M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedMay 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
Offering amount
$5.9M
Amount sold
$5.9M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedMay 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • John E. RunnellsExecutive Officer
  • Jonathan RootDirector
  • Jack LasersohnExecutive Officer, Director
Offering amount
$5.9M
Amount sold
$5.9M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Route 92 Medical do?
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment. Its products are designed to navigate tortuous vascular anatomy and reach target locations for procedures such as aspiration.
Who founded Route 92 Medical?
Route 92 Medical was founded by Dr. Chou in 2015.
Who are Route 92 Medical's investors?
Route 92 Medical's investors include Norwest Venture Partners, Runway Growth Capital, US Venture Partners, Sofinnova Ventures, The Vertical Group.
How much funding has Route 92 Medical raised?
Route 92 Medical has disclosed $208.1M raised across 8 rounds.
Where is Route 92 Medical headquartered?
Route 92 Medical is headquartered in San Mateo, US.